List of Excipients in API clindamycin palmitate hydrochloride (pediatric)
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing clindamycin palmitate hydrochloride (pediatric)
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| NorthStar Rx LLC | clindamycin palmitate hydrochloride (pediatric) | 16714-483 | CHERRY |
| NorthStar Rx LLC | clindamycin palmitate hydrochloride (pediatric) | 16714-483 | DIMETHICONE |
| NorthStar Rx LLC | clindamycin palmitate hydrochloride (pediatric) | 16714-483 | ETHYLPARABEN |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for clindamycin palmitate hydrochloride (pediatric)
Excipient focus: CHERRY
clindamycin palmitate hydrochloride (pediatric) drug variants containing CHERRY
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | clindamycin palmitate hydrochloride (pediatric) | 16714-483 |
| Aurobindo Pharma Limited | clindamycin palmitate hydrochloride (pediatric) | 65862-596 |
| >Company | >Ingredient | >NDC |
clindamycin palmitate hydrochloride (pediatric) drug variants not containing CHERRY
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
clindamycin palmitate hydrochloride (pediatric) drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | clindamycin palmitate hydrochloride (pediatric) | 16714-483 |
| Aurobindo Pharma Limited | clindamycin palmitate hydrochloride (pediatric) | 65862-596 |
| >Company | >Ingredient | >NDC |
clindamycin palmitate hydrochloride (pediatric) drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLPARABEN
clindamycin palmitate hydrochloride (pediatric) drug variants containing ETHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | clindamycin palmitate hydrochloride (pediatric) | 16714-483 |
| Aurobindo Pharma Limited | clindamycin palmitate hydrochloride (pediatric) | 65862-596 |
| >Company | >Ingredient | >NDC |
clindamycin palmitate hydrochloride (pediatric) drug variants not containing ETHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ICODEXTRIN
clindamycin palmitate hydrochloride (pediatric) drug variants containing ICODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | clindamycin palmitate hydrochloride (pediatric) | 16714-483 |
| Aurobindo Pharma Limited | clindamycin palmitate hydrochloride (pediatric) | 65862-596 |
| >Company | >Ingredient | >NDC |
clindamycin palmitate hydrochloride (pediatric) drug variants not containing ICODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
clindamycin palmitate hydrochloride (pediatric) drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | clindamycin palmitate hydrochloride (pediatric) | 16714-483 |
| Aurobindo Pharma Limited | clindamycin palmitate hydrochloride (pediatric) | 65862-596 |
| >Company | >Ingredient | >NDC |
clindamycin palmitate hydrochloride (pediatric) drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
clindamycin palmitate hydrochloride (pediatric) drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | clindamycin palmitate hydrochloride (pediatric) | 16714-483 |
| Aurobindo Pharma Limited | clindamycin palmitate hydrochloride (pediatric) | 65862-596 |
| >Company | >Ingredient | >NDC |
clindamycin palmitate hydrochloride (pediatric) drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
clindamycin palmitate hydrochloride (pediatric) drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | clindamycin palmitate hydrochloride (pediatric) | 16714-483 |
| Aurobindo Pharma Limited | clindamycin palmitate hydrochloride (pediatric) | 65862-596 |
| >Company | >Ingredient | >NDC |
clindamycin palmitate hydrochloride (pediatric) drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
clindamycin palmitate hydrochloride (pediatric) drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | clindamycin palmitate hydrochloride (pediatric) | 16714-483 |
| Aurobindo Pharma Limited | clindamycin palmitate hydrochloride (pediatric) | 65862-596 |
| >Company | >Ingredient | >NDC |
clindamycin palmitate hydrochloride (pediatric) drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
